Clinical Trial Update: Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for eplerenone in patients undergoing renal transplant (EPURE TRANSPLANT) for end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• eplerenone (eplerenone)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: End-stage Renal Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING